3 independently sourced, verified trend briefs about this subject.
Newsylist includes a story here only after at least four independent sources support it and its brief passes the verification check. The qualifying coverage spans 2 news categories, from Jul 24, 2026 through Aug 20, 2026.
The cards below are ordered newest first. Each opens the underlying timeline, source list, coverage velocity and verification context; raw or extractive-only records are excluded.
Moderna shares surged following trial results for a personalized mRNA melanoma vaccine developed with Merck.
The first mRNA-based influenza vaccine has received federal approval in the United States.
The world's first vaccine targeting the Bundibugyo ebolavirus has entered human clinical trials following the first volunteer vaccination.